Dr. Perlewitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1003 Providence Dr
Ste 310
Newberg, OR 97132Phone+1 503-537-6040Fax+1 503-537-6045
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2007 - 2010
Temple University HospitalResidency, Internal Medicine, 2004 - 2007
Rutgers Robert Wood Johnson Medical SchoolClass of 2004
Certifications & Licensure
OR State Medical License 2007 - 2025
PA State Medical License 2004 - 2007- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
- Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Start of enrollment: 2011 Jul 01
- Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer Start of enrollment: 2010 Oct 14
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsA Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer.David B. Page, Joanna Pucilowska, Katherine Sanchez, Valerie Conrad, Alison Conlin
Clinical Cancer Research. 2020-04-01 - 7 citationsEpirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas.Eric Lu, Kelly Shea Perlewitz, James B. Hayden, Arthur Y. Hung, Yee Cheen Doung
Annals of Surgical Oncology. 2018-01-31 - 63 citationsPhase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates.Janelle M. Meyer, Kelly Shea Perlewitz, James B. Hayden, Yee Cheen Doung, Arthur Y. Hung
Clinical Cancer Research. 2013-12-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
